Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, MC 0684, La Jolla, California, 92093, USA.
Center for Proteomics and Bioinformatics and Department of Nutrition, Case Western Reserve University School of Medicine, 10009 Euclid Avenue, Cleveland, Ohio 44109, USA.
Nat Commun. 2017 Jan 18;8:14135. doi: 10.1038/ncomms14135.
Chemokines drive cell migration through their interactions with seven-transmembrane (7TM) chemokine receptors on cell surfaces. The atypical chemokine receptor 3 (ACKR3) binds chemokines CXCL11 and CXCL12 and signals exclusively through β-arrestin-mediated pathways, without activating canonical G-protein signalling. This receptor is upregulated in numerous cancers making it a potential drug target. Here we collected over 100 distinct structural probes from radiolytic footprinting, disulfide trapping, and mutagenesis to map the structures of ACKR3:CXCL12 and ACKR3:small-molecule complexes, including dynamic regions that proved unresolvable by X-ray crystallography in homologous receptors. The data are integrated with molecular modelling to produce complete and cohesive experimentally driven models that confirm and expand on the existing knowledge of the architecture of receptor:chemokine and receptor:small-molecule complexes. Additionally, we detected and characterized ligand-induced conformational changes in the transmembrane and intracellular regions of ACKR3 that elucidate fundamental structural elements of agonism in this atypical receptor.
趋化因子通过与细胞表面的七跨膜 (7TM) 趋化因子受体相互作用来驱动细胞迁移。非典型趋化因子受体 3 (ACKR3) 结合趋化因子 CXCL11 和 CXCL12,并通过β-arrestin 介导的途径专门发出信号,而不激活经典 G 蛋白信号通路。该受体在许多癌症中上调,使其成为潜在的药物靶点。在这里,我们从放射化学足迹、二硫键捕获和诱变中收集了超过 100 种不同的结构探针,以绘制 ACKR3:CXCL12 和 ACKR3:小分子复合物的结构图谱,包括通过同源受体的 X 射线晶体学无法解决的动态区域。这些数据与分子建模相结合,生成完整且一致的、受实验驱动的模型,这些模型证实并扩展了受体:趋化因子和受体:小分子复合物结构的现有知识。此外,我们检测并表征了 ACKR3 跨膜和细胞内区域的配体诱导构象变化,阐明了该非典型受体激动剂的基本结构元件。